2 results
  • myfembree

    (relugolix, estradiol hemihydrate, and norethindrone acetate)
    Sumitomo Pharma America, Inc
    MYFEMBREE is indicated for managing heavy menstrual bleeding due to uterine leiomyomas and for moderate to severe pain associated with endometriosis in premenopausal women. Its use should be limited to 24 months to mitigate the risk of irreversible bone loss.
  • orgovyx

    (relugolix)
    Sumitomo Pharma America, Inc
    ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer.